Search results for:

40 Post(s)

21 June 2021
UK SPINE Recording

Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the field of Geroscience to accelerate the drug development process. Related Resources

Read More
21 June 2021
Microbiome SIG Webinar Series

Our CEO, Dr. David Weinkove, explains how healthspan readouts can be used to understand mechanisms in the microbiome. De-risking drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegeneration and the microbiome using C. elegans. Related Resources

Read More
21 June 2021
Automated Imaging of C. elegans for Ageing, Neurodegeneration and Behaviour

How large scale non-invasive imaging of C. elegans to enable reliable measurement of Ageing, Neurodegeneration and Behaviour. Related Resources

Read More
21 June 2021
C. elegans Automated Imaging in Drug Discovery

De-risking drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegeneration and the microbiome using C. elegans. Related Resources

Read More
21 June 2021
An overview of the use of C. elegans in longevity research including the genetic manipulation of animals.

An overview of the use of C. elegans in longevity research including the genetic manipulation of animals.

Read More
7 June 2021
Magnitude Biosciences recognised in Developed in Durham as local success story

Magnitude Biosciences has been recognised by Developed in Durham.

Read More
3 June 2021
Magnitude Biosciences to attend Translating Ideas Into Therapies 2021 and the International C. elegans Conference in June 2021

June 2021 marks an exciting month as we see some of our C. elegans thought leaders speaking at key events. The 23rd Biannual International C. elegans conference will be held over 21st - 24th of June. #Worm2021 has been reimagined to take place online to feature virtual discussion sessions, interactive workshops and connect worm experts […]

Read More
27 May 2021
A child, a worm, and a new era of drug discovery

This article will tell the story of how C. elegans enabled a life-changing effects drug therapy for a child suffering from a rare disease

Read More
22 May 2021
Magnitude Biosciences launches new website

Magnitude Biosciences, the world’s leading C. elegans Contract Research Organisation (CRO) and commercial lab, is on an amazing journey. When we started in 2018, the potential of C. elegans to address research challenges was largely unknown to biotechs and the R&D teams of large manufacturing, health products and consumer goods companies. Now, in 2021, we […]

Read More
7 November 2023
The worm angle on the taurine story: a route to the clinic by understanding mechanism

Dr Manish Chamoli in the lab of Gordon Lithgow at the Buck Institute (Right) David Weinkove, 15 June 2023 A recent research article in Science showed that supplementing with taurine slows ageing across a number of species: mouse, zebrafish, monkey and my favourite model organism the worm C. elegans. The worm may seem a lowly […]

Read More

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research

© 2025 Magnitude Biosciences Ltd. All rights reserved.

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram